Class of Stock [Axis]
Series A Preferred Stock [Member]
Product and Service [Axis]
Sales 1 [Member]
Equity Components [Axis]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Common Stock Subscribed [Member]
Subscription Receivable [Member]
Retained Earnings [Member]
Parent [Member]
Noncontrolling Interest [Member]
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Concentration Risk Type [Axis]
Customer Concentration Risk [Member]
Customer [Axis]
One Customers [Member]
Advertising Campaigns [Member]
Two Customers [Member]
Consensi Product [Member]
Counterparty Name [Axis]
Purple Bio Tech [Member]
Legal Entity [Axis]
CD38 Assets [Member]
Vy Gen [Member]
Transaction Type [Axis]
Co Development Rights [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
License Agreement [Member]
Related and Nonrelated Parties [Axis]
Long-Term Debt, Type [Axis]
Oct 2022 Convertible Promissory Note [Member]
Debt Instrument [Axis]
Yorkville Convertible Note [Member]
Derivative Instrument [Axis]
Standby Equity Purchase Agreement [Member]
YA Note-2 [Member]
Measurement Input Type [Axis]
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 3 [Member]
Measurement Input, Price Volatility [Member]
Measurement Input, Conversion Price [Member]
Measurement Input, Share Price [Member]
Eidl Loan [Member]
Award Type [Axis]
Public Warrants [Member]
Sale of Stock [Axis]
Private Placement Warrants [Member]
Measurement Frequency [Axis]
Fair Value, Recurring [Member]
Fair Value, Inputs, Level 1 [Member]
Warrants [Member]
Measurement Input, Exercise Price [Member]
Warrant Liabilities [Member]
Warrant Note Subscription Receivables [Member]
Private Placement [Member]
SNAP Biosciences Inc [Member]
Two Investor [Member]
Consulting Agreement [Member]
Stock Options [Member]
Modification [Member]
Equity Incentive Plan 2022 [Member]
Financial Instrument [Axis]
Subscription Receivable Sept 2023 [Member]
Yorkville [Member]
Stock Issued For Services [Member]
Convertible Note [Member]
Warrant Holder 1 Exercise Price 59. 40 [Member]
Warrant Holder 1 Exercise Price 118. 80 [Member]
Warrant Holder 1 Exercise Price 296. 80 [Member]
Warrant Holder 2 Exercise Price 59. 40 [Member]
Warrant Holder 2 Exercise Price 296. 80 [Member]
Warrant Holder 5 Exercise Price 59. 40 [Member]
Warrant Holder 20 Exercise Price 50. 00 [Member]
Warrant Holder 21 Exercise Price 38. 00 [Member]
Series Warrants A And B Exercise Price 27. 20 [Member]
Series B Warrants Exercise Price 27. 20 [Member]
Warrant Holder 22 Exercise Price 25. 00 [Member]
Warrant Holder 22 Exercise Price 28. 00 [Member]
Warrant Holder 23 Exercise Price 25. 00 [Member]
Warrant Holder 23 Exercise Price 28. 00 [Member]
Warrant Holder 24 Exercise Price 28. 00 [Member]
Warrant Holder 25 Exercise Price 12. 00 [Member]
Gear Therapeutics [Member]
Two Privately Held Companies [Member]
Nex Gen AI Affiliates Network Platform [Member]
Five Privately Held Companies [Member]
Three Privately Held Companies [Member]
Privately Held Company [Member]
Investment Type [Axis]
Third Party Marketable Security [Member]
Privately Held Companies [Member]
Long-Lived Asset, Class [Axis]
First Year Extension [Member]
Second Year Extension [Member]
First Year Extension 1 [Member]
Second Year Extension 1 [Member]
Car T License [Member]
Finders Fee And Indemnity Agreement [Member]
Master Services Agreements [Member]
Gear Cell Therapy Platform [Member]
AG Bio Life CapitalI LP [Member]
Nex Gen AI Solutions Group Inc [Member]
Intangible Asset, Finite-Lived, Class [Axis]
Nex Gen AI [Member]
Segments [Axis]
Biotechnology Segment [Member]
Technology Segment [Member]
Biotechnology [Member]
Technology [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Information, Former Legal or Registered Name
Statement [Table]
Statement [Line Items]
ASSETS
CURRENT ASSETS
Cash
Marketable securities
Interest receivable
Prepaid assets
TOTAL CURRENT ASSETS
PROPERTY AND EQUIPMENT
Furniture and fixtures, net
OTHER ASSETS
Investments
Intangible assets, net
Co-development rights, net
Right of use asset, net of accumulated amortization
Total other assets
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable
Accrued expenses
Convertible notes payable, in default
Right of use liability, current portion
Customer deposit
Other current liabilities
TOTAL CURRENT LIABILITIES
LONG TERM LIABILITIES
SBA loan payable
Derivative liability warrants
Right of use liability, non-current portion
TOTAL LONG TERM LIABILITIES
TOTAL LIABILITIES
COMMITMENTS AND CONTINGENCIES (NOTE 10)
STOCKHOLDERS’ EQUITY
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 10,000 designated as Series A, zero shares issued and outstanding
Common stock, $0.0001 par value, 150,000,000 shares authorized, 6,553,996 and 5,746,948 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively
Additional paid-in capital
Subscription receivable
Accumulated deficit
TOTAL STOCKHOLDERS’ EQUITY - CONTROLLING INTERESTS
TOTAL STOCKHOLDERS’ EQUITY - NONCONTROLLING INTERESTS
TOTAL STOCKHOLDERS’ EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
SALES
Total sales
Cost of goods
Gross profit
COST OF OPERATIONS
Research and development expense
Salary expense
Amortization expense
Professional services expense
Stock based compensation expense
General and administrative expenses
Selling and marketing expense
Total cost of operations
LOSS FROM OPERATIONS
OTHER (EXPENSE) INCOME
Interest expense
Other income, net
Unrealized loss on marketable securities
Unrealized loss on investments
Realized gain on sale of marketable securities
Change in fair value of derivative liabilities
TOTAL OTHER (EXPENSE) INCOME, net
LOSS BEFORE INCOME TAXES
PROVISION FOR INCOME TAXES (BENEFIT)
NET LOSS
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS
NET LOSS
LOSS PER SHARE
Loss per share, basic
Loss per share, fully diluted
Weighted average number of common shares outstanding, basic
Weighted average number of common shares outstanding, diluted
Beginning balance, value
Beginning balance, shares
Series A preferred stock offering
Series A preferred stock offering, shares
Pre-funded warrants exercise
Pre-funded warrants exercise, shares
Preferred share conversion
Preferred share conversion, shares
Shares issued for services
Shares issued for services, shares
Shares issued for SEPA
Shares issued for SEPA, shares
Shares issued for investment
Shares issued for investment, shares
Stock option exercised
Stock option exercised, shares
Asset purchase agreement
Asset purchase agreement, shares
Stock based compensation
Warrants issued for services
Net loss
Ending balance, value
Ending balance, shares
Statement of Cash Flows [Abstract]
OPERATING ACTIVITIES
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization
Right of use asset amortization
Amortization of debt discount
Non-cash revenue
Stock based compensation
Shares issued for non-employee services
Warrants issued for services
Change in fair value of derivative liability
Change in fair value of derivative liability warrants
Realized gain on sale of marketable securities
Forgiveness of interest
Unrealized loss on investments
Unrealized loss on marketable securities
(Increase) decrease in:
Interest receivable
Prepaid assets
Increase (decrease) in:
Accounts payable
Accrued expenses
Customer deposit
Right of use liability
Other current liabilities
NET CASH USED IN OPERATING ACTIVITIES
INVESTING ACTIVITIES
Sale of marketable securities
NET CASH PROVIDED BY INVESTING ACTIVITIES
FINANCING ACTIVITIES
Proceeds from notes payable
Repayment of notes payable
Shares issued for SEPA
Warrants issued for cash
Stock option exercised
Preferred stock offering
NET CASH PROVIDED BY FINANCING ACTIVITIES
NET (DECREASE) INCREASE IN CASH
CASH AT BEGINNING OF PERIOD
CASH AT END OF PERIOD
SUPPLEMENTAL CASH FLOW DISCLOSURES
Interest paid
Taxes paid
SUPPLEMENTAL NON-CASH DISCLOSURES
Shares issued for investment
Investments received for stock options exercised
Increase in right of use assets due to lease renewal
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Trading Arrangements, by Individual [Table]
Trading Arrangement [Axis]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Accounting Policies [Abstract]
DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Co-development Rights
CO-DEVELOPMENT RIGHTS
Debt Disclosure [Abstract]
CONVERTIBLE NOTES
Sba Loan Payable
SBA LOAN PAYABLE
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE LIABILITY WARRANTS
Equity [Abstract]
CAPITAL STRUCTURE
Noncontrolling Interest [Abstract]
NON-CONTROLLING INTEREST
Investments, All Other Investments [Abstract]
INVESTMENTS
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Retirement Benefits [Abstract]
401(k) PROFIT-SHARING PLAN
Income Tax Disclosure [Abstract]
INCOME TAXES
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTION
Intangible Asset, Goodwill and Other [Abstract]
INTANGIBLE ASSETS
Segment Reporting [Abstract]
SEGMENT REPORTING
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]
MERGER AGREEMENT
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Use of Estimates
Reclassification
Employee and Non-Employee Share-Based Compensation
Recent Accounting Pronouncements
Revenue Recognition
Investments and Marketable Securities
Going Concern
Schedule of assumptions used for valuation
Schedule of changes in fair value of derivative liability
Schedule of fair value hierarchy
Schedule of fair value assumptions
Schedule of changes in fair value of warrant liabilities
Schedule of stock option activity
Schedule of weighted average assumptions
Schedule of warrants outstanding
Schedule of lease information
Schedule of future minimum rental payments
Schedule of segment information
Nature of Operation, Product Information, Concentration of Risk [Table]
Product Information [Line Items]
Concentration risk percentage
Revenues
Customer deposits
Accumulated deficit
Net loss
DisclosureTable [Table]
CoDevelopmentLineItems [Line Items]
Issuance of convertible debt
Outstanding principal balance
Outstanding principal balance
Payments to Acquire Productive Assets
Other Notes Payable, Noncurrent
Total gross capitalized co-development rights
License fees
Accumulated amortization
Net carrying amount
Business Combination [Table]
Business Combination [Line Items]
Derivative assumption valuation
Fair value of derivative liability, beginning balance
Change in fair value
Extinguishment of fair value of liability
Fair value of derivative liability, ending balance
Schedule of Long-Term Debt Instruments [Table]
Debt Instrument [Line Items]
Convertible promissory note
Interest rate
Convertible notes outstanding
Repayment of convertible debt
Debt in default
Interest rate
Debt Conversion, Converted Instrument, Amount
Accrued interest
Shares issued
Conversion price
Remaining principal balance
Fair value derivative liability
Change in fair value of derivative liability
Transfers in or out of Level 3
Warrant liabilities outstanding
Maturity date
Proceeds from loans
Accrued interest rate
Notes payable
Derivative Instruments, Gain (Loss) [Table]
Derivative Instruments, Gain (Loss) [Line Items]
Financial liabilities fair value disclosure
Derivatives, determination of fair value
Fair value of liabilities, beginning
Change in valuation inputs
Fair value of liabilities, ending
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants outstanding
Options outstanding, beginning
Weighted average exercise price, beginning balance outstanding
Weighted average contractual life (years), options outstanding
Intrinsic value, options outstanding
Options granted
Weighted average exercise price, granted
Options exercised
Weighted average exercise price, exercised
Options surrendered
Weighted average exercise price, surrendered
Options outstanding, ending
Weighted average exercise price, ending balance outstanding
Expected term, in years
Expected volatility
Risk-free interest rate
Dividend yield
Stock, Class of Stock [Table]
Class of Stock [Line Items]
Date Issued
Warrants exercise price
Expiration
Total warrants outstanding
Common Stock, Shares Authorized
Preferred stock authorized
Aggregate exercise price of warrant
Proceeds from common stock
Investors description
Gross proceeds
Number of shares issued
Principal amount
Debt instrument stated percentage
Maturity period
Treasury stock
Proceeds from sale of preferred stock
Subscription receivable
Conversion of stock, shares converted
Stock-based compensation expense
Unamortized stock-based compensation
Stock issued for debt, value
Number of shares forfeited
Exercise price of warrants
Number of shares expired
Proceeds from issuance of preferred stock
Subscription receivable
Subscriptions receivable
Proceeds subscriptions receivable
Subscriptions receivable net
Payment of commitment fee
Noncontrolling Interest [Table]
Noncontrolling Interest [Line Items]
Net of accumulated losses
Equity attributable to non-controlling interests
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Subscription receivables and related interest receivable
Investment shares
Loss on investment
Issued shares of common stock, shares
Issued shares of common stock, value
Investment company fee paid shares indirectly
Investment company fee paid indirectly
Unrealized gain on marketable securities
Marketable security sold
Realized gain on marketable securities
Investment value
Sale of marketable securities
Realizing loss on marketable securities
Impairment on investments
Number of shares exchanged
Number of shares exchanged, value
Unrealized loss on investment
Operating lease right of use asset, gross
Operating lease right of use asset, accumulated depreciation
Operating lease right of use asset
Operating lease liability
Operating lease liability, current
Operating lease liability, noncurrent
2026
2027
2028
Total minimum lease payments:
Less amount representing interest
Present value of minimum lease payments:
Property, Plant, and Equipment [Table]
Property, Plant, and Equipment [Line Items]
[custom:MonthlyRent]
[custom:RightOfUseLiabilityShares-0]
Operating lease expense
Initial license fee
Annual maintenance fee description
Contractual obligation
Agreement amendment fee
Payment for fees
Customer deposit receivable
Defined Benefit Plan, Assumptions Used in Calculation, Description
Employer contributions
Income Tax Expense (Benefit)
Related Party Transaction [Line Items]
Shares issued
Note receivable
Investment
Other investments
Intangible Asset, Finite-Lived [Table]
Intangible Asset, Finite-Lived [Line Items]
Stock issued for purchase of assets, shares
Stock issued for purchase of assets, value
Intangible Asset, Excluding Goodwill, after Accumulated Amortization
Amortization of intangible assets
Segment Reporting [Table]
Segment Reporting [Line Items]
Sales
Cost of goods sold
Total operating expenses
Net (loss) gain from operations
Number of operating segments
Number of reportable segments
Total assets
Assets, Current
Other Assets
Liabilities, Current
Liabilities, Noncurrent
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Gross Profit
Interest Expense, Nonoperating
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Net Income (Loss) Attributable to Noncontrolling Interest
Shares, Outstanding
Other Noncash Income
Employee Benefit and Share-Based Payment Arrangement, Noncash
WarrantsIssuedForServices
Increase (Decrease) in Interest and Dividends Receivable
Increase (Decrease) in Prepaid Expense
Increase (Decrease) in Other Accounts Payable
Increase (Decrease) in Accrued Liabilities
IncreaseDecreaseInCustomerDeposit
Increase (Decrease) in Other Current Liabilities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
SharesIssuedForSepa
Proceeds from Stock Options Exercised
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation
SharesIssuedForInvestment
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Derivative Liability, Subject to Master Netting Arrangement, before Offset
Extinguishment of Debt, Gain (Loss), Net of Tax
Liabilities, Fair Value Disclosure
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Preferred Stock, Shares Subscribed but Unissued, Subscriptions Receivable
SaleOfMarketableSecurities
OperatingLeaseRightOfUseAssetAccumulatedDepreciation
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Stock Issued During Period, Shares, Other